Related Experiment Video
Updated: Apr 28, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Predicting natural product value, an exploration of anti-TB drug space
Yousef Dashti1, Tanja Grkovic, Ronald J Quinn
1Eskitis Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia. yousef.dashti@griffithuni.edu.au t.grkovic@griffith.edu.au r.quinn@griffith.edu.au.
Abstract:
Covering: January 1990 to December 2012. Mycobacterium tuberculosis (Mtb) still remains a deadly pathogen two decades after the announcement of tuberculosis (TB) as a global health emergency by the World Health Organization. In last few years new drug combinations have shown promising potential to significantly shorten TB treatment times. However there are very few new chemical entities being developed to treat this global threat. From January 1990 to December 2012, 949 anti-mycobacterium natural products were reported in the literature. Here we present a perspective based on an analysis of the drug-like properties of the reported anti-mycobacterium natural products in order to assess drug potential.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

